Breaking News

Lilly Invests $7.5M in Indiana Biosciences

Will support biosciences research in the state

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Eli Lilly and Co. is investing $7.5 million toward startup of the Indiana Biosciences Research Institute. “This represents a significant investment by Lilly in the future of Indiana and in the future of biosciences research,” said John C. Lechleiter, Ph.D., chairman and chief executive officer of Lilly. “Each year in Indiana, billions of dollars are invested in R&D to advance medical innovation. This institute will help Indiana attract additional global talent and will nurture partners...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters